[go: up one dir, main page]

SI3285777T1 - Glikanski terapevtiki in postopki zdravljenja - Google Patents

Glikanski terapevtiki in postopki zdravljenja

Info

Publication number
SI3285777T1
SI3285777T1 SI201631301T SI201631301T SI3285777T1 SI 3285777 T1 SI3285777 T1 SI 3285777T1 SI 201631301 T SI201631301 T SI 201631301T SI 201631301 T SI201631301 T SI 201631301T SI 3285777 T1 SI3285777 T1 SI 3285777T1
Authority
SI
Slovenia
Prior art keywords
treatment
methods
glycan therapeutics
glycan
therapeutics
Prior art date
Application number
SI201631301T
Other languages
English (en)
Inventor
Maltzahn Geoffrey A. Von
Yvonne J. Yamanaka
Jared Silverman
Jack Milwid
Jacob R. RUBENS
John M. Geremia
Original Assignee
Kaleido Biosciences, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kaleido Biosciences, Inc. filed Critical Kaleido Biosciences, Inc.
Publication of SI3285777T1 publication Critical patent/SI3285777T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/733—Fructosans, e.g. inulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
SI201631301T 2015-04-23 2016-04-23 Glikanski terapevtiki in postopki zdravljenja SI3285777T1 (sl)

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
US201562152011P 2015-04-23 2015-04-23
US201562152017P 2015-04-23 2015-04-23
US201562152007P 2015-04-23 2015-04-23
US201562216997P 2015-09-10 2015-09-10
US201562216995P 2015-09-10 2015-09-10
US201562238112P 2015-10-06 2015-10-06
US201562238110P 2015-10-06 2015-10-06
US201662278333P 2016-01-13 2016-01-13
EP16722465.8A EP3285777B1 (en) 2015-04-23 2016-04-23 Glycan therapeutics and methods of treatment
PCT/US2016/029082 WO2016172657A2 (en) 2015-04-23 2016-04-23 Glycan therapeutics and methods of treatment

Publications (1)

Publication Number Publication Date
SI3285777T1 true SI3285777T1 (sl) 2022-02-28

Family

ID=55967431

Family Applications (1)

Application Number Title Priority Date Filing Date
SI201631301T SI3285777T1 (sl) 2015-04-23 2016-04-23 Glikanski terapevtiki in postopki zdravljenja

Country Status (11)

Country Link
US (4) US20180147221A1 (sl)
EP (2) EP3285777B1 (sl)
JP (2) JP2018517677A (sl)
CN (2) CN116270718A (sl)
AU (2) AU2016253010B2 (sl)
CA (1) CA2983236A1 (sl)
DK (1) DK3285777T3 (sl)
ES (1) ES2895725T3 (sl)
LT (1) LT3285777T (sl)
SI (1) SI3285777T1 (sl)
WO (1) WO2016172657A2 (sl)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019090180A1 (en) 2017-11-03 2019-05-09 Kaleido Biosciences, Inc. Glycan preparations for the treatment of infection
US10752705B2 (en) 2014-07-09 2020-08-25 Cadena Bio, Inc. Oligosaccharide compositions and methods for producing thereof
ES2857557T3 (es) 2015-01-26 2021-09-29 Kaleido Biosciences Inc Compuestos terapéuticos de glicano y métodos relacionados de los mismos
EP4205553A1 (en) 2015-01-26 2023-07-05 DSM Nutritional Products, LLC Oligosaccharide compositions for use animal feed and methods of producing thereof
CA2983236A1 (en) 2015-04-23 2016-10-27 Kaleido Biosciences, Inc. Glycan therapeutics and methods of treatment
DE112016002056T5 (de) 2015-05-06 2018-02-08 Snipr Technologies Limited Verändern mikrobieller Populationen und Modifizieren von Mikrobiomen
PT3626081T (pt) * 2015-09-10 2022-02-25 Univ Catholique Louvain Akkermansia pasteurizada para promover a perda de peso
GB201609811D0 (en) * 2016-06-05 2016-07-20 Snipr Technologies Ltd Methods, cells, systems, arrays, RNA and kits
JP2019527213A (ja) 2016-07-13 2019-09-26 カレイド・バイオサイエンシズ・インコーポレイテッド グリカン組成物および使用方法
TWI673056B (zh) * 2016-07-22 2019-10-01 大江生醫股份有限公司 包含細菌的水凝膠及其製備方法
ES2967947T3 (es) 2016-12-06 2024-05-06 Dsm Nutritional Products Llc Polímeros de glicano y métodos relacionados de los mismos
WO2018145082A1 (en) * 2017-02-06 2018-08-09 New York University Methods and compositions for treating and diagnosing pancreatic cancers
WO2018187802A1 (en) * 2017-04-07 2018-10-11 The Trustees Of Columbia University In The City Of New York Characterization of the oral microbiome for the non-invasive diagnosis of barrett's esophagus
WO2018229519A1 (en) * 2017-06-12 2018-12-20 Debreceni Egyetem Methods for diagnosing breast cancer
MA51770A (fr) 2017-07-05 2020-05-13 Evelo Biosciences Inc Compositions et méthodes de traitement du cancer à l'aide de bifidobacterium animalis ssp. lactis
WO2019014645A1 (en) 2017-07-13 2019-01-17 Kaleido Biosciences, Inc. GLYCAN COMPOSITIONS AND METHODS OF USE
US11865145B2 (en) * 2017-08-07 2024-01-09 Finch Therapeutics Holdings Llc Compositions and methods for maintaining and restoring a healthy gut barrier
EP3703705B1 (en) 2017-11-03 2024-05-15 DSM Nutritional Products, LLC Glucose-containing glycan preparations for use in the treatment of hyperammonaemia
WO2019090181A1 (en) 2017-11-03 2019-05-09 Kaleido Biosciences, Inc. Methods of producing glycan polymers
WO2019099482A1 (en) * 2017-11-14 2019-05-23 Evelo Biosciences, Inc. Compositions and methods for treating disease using a blautia strain
KR102282490B1 (ko) 2018-01-12 2021-07-28 주식회사 엠디헬스케어 패칼리박테리움 프라우스니찌 유래 나노소포 및 이의 용도
EP3762486A1 (en) * 2018-03-09 2021-01-13 Nutrition & Biosciences USA 4, Inc. Engineered glucosyltransferases
US10760075B2 (en) 2018-04-30 2020-09-01 Snipr Biome Aps Treating and preventing microbial infections
CN108653341B (zh) * 2018-05-30 2021-04-30 华中科技大学 一种用于恶性肿瘤免疫治疗的药盒及其应用
IT201800006815A1 (it) * 2018-06-29 2019-12-29 An organic-inorganic hybrid material comprising a metal and lignin, processes for preparing the same and uses thereof / materiale ibrido organico-inorganico comprendente metallo e lignina, processi per la sua preparazione e suoi usi
CN109022317B (zh) * 2018-08-15 2022-04-05 河南金百合生物科技股份有限公司 一种丁酸梭菌菌粉的制备方法
US12410206B2 (en) 2018-08-21 2025-09-09 Dsm Nutritional Products, Llc Oligosaccharide compositions and methods of use thereof for reducing ammonia levels
CN113260635B (zh) * 2018-11-08 2023-10-31 Dsm营养产品有限责任公司 寡糖组合物及其使用方法
AU2020235358A1 (en) * 2019-03-11 2021-10-07 Alma Mater Studiorum - Università di Bologna Bacterium of the Christensenellaceae Family For The Prevention And/Or Treatment Of Chronic Inflammatory Diseases And/Or Inflammatory Gastrointestinal Diseases And/Or Cancers
JP7741064B2 (ja) 2019-08-28 2025-09-17 エックスバイオーム インコーポレーテッド 細菌種を含む組成物及びそれに関連する方法
CN110592056A (zh) * 2019-09-19 2019-12-20 昆明理工大学 噬菌体裂解酶复合粉剂及其制备方法和应用
CA3151747A1 (en) * 2019-09-23 2021-04-01 James J. MOON Compositions and methods for increasing the efficacy of immunotherapies and vaccines
WO2021087072A1 (en) * 2019-10-29 2021-05-06 Mohapatra Shyam S Compositions and methods for preventing and treating respiratory syncytial virus infection
CN114760992A (zh) * 2019-11-27 2022-07-15 帝斯曼知识产权资产管理有限公司 包含核黄素的mups片剂
CN110787171A (zh) * 2019-12-11 2020-02-14 浙江华康药业股份有限公司 槐糖在预防和治疗炎症性肠病产品中的应用及对应产品
CN110946871A (zh) * 2019-12-12 2020-04-03 浙江华康药业股份有限公司 槐糖在制备预防和治疗肥胖产品中的应用及对应产品
CN111603500B (zh) * 2020-06-30 2022-03-04 河南中大恒源生物科技股份有限公司 一种决明子提取物及决明子综合开发利用的工艺技术
EP4181910A4 (en) * 2020-07-17 2024-06-05 DSM Nutritional Products, LLC OLIGOSACCHARIDE COMPOSITIONS AND METHODS OF USE
AU2021350104A1 (en) * 2020-09-25 2023-06-08 Dsm Nutritional Products, Llc Oligosaccharide compositions and methods of use
CN116568312A (zh) * 2020-12-01 2023-08-08 西雅图咖米公司 稳定的半固体可咀嚼凝胶组合物及其制作和使用方法
US20240309408A1 (en) * 2021-05-13 2024-09-19 Bcd Bioscience, Inc. Methods of Use of Oligosaccharide Compositions for Modulating Microbiota and their Metabolic Products, and as Therapeutics for Health Applications
CN114381406B (zh) * 2022-01-27 2023-06-13 江南大学 可同时降低血浆及盲肠三甲胺的短双歧杆菌ccfm1217及其应用
US11759434B2 (en) * 2022-02-03 2023-09-19 Sytheon Limited Methods and compositions for treating melanoma and non-melanoma skin cancers
WO2023148525A1 (en) * 2022-02-04 2023-08-10 Health And Happiness (H&H) Hong Kong Ltd 2'-fucosyllactose and lacto-n-neotetraose for preventing and treating overweight
CN114452305B (zh) * 2022-03-17 2024-07-26 北京航空航天大学 单形拟杆菌用于制造预防与治疗焦虑抑郁症药物中的应用
CN114788837B (zh) * 2022-06-07 2023-09-05 青岛东海药业有限公司 一种组合物及其在制备治疗和/或预防化疗引起的恶心呕吐的药物中的应用
GB202209518D0 (en) 2022-06-29 2022-08-10 Snipr Biome Aps Treating & preventing E coli infections
US20250319027A1 (en) * 2022-07-01 2025-10-16 Vitakey Inc. Nutraceutical particles
CN115400155B (zh) * 2022-08-17 2024-10-29 中南大学 缓解产后抑郁的益生菌组合物及其制备方法和应用
WO2024144752A2 (en) * 2022-12-31 2024-07-04 Si̇lver Shell Sağlik Ürünleri̇ Anoni̇m Şi̇rketi̇ Ahcc characterization for use in different forms and related method
WO2024144751A1 (en) * 2022-12-31 2024-07-04 Si̇lver Shell Sağlik Ürünleri̇ Anoni̇m Şi̇rketi̇ Ahcc characterization for use in different forms and related method
CN116918951B (zh) * 2023-06-27 2025-06-17 河北喜之郎食品有限公司 一种魔芋微粉的制备方法及其应用
CN119054783A (zh) * 2024-11-01 2024-12-03 中国农业科学院饲料研究所 植物乳杆菌lp4在制备微生态制剂中的应用

Family Cites Families (136)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2027904A (en) 1933-02-16 1936-01-14 Int Suiker En Alcohol Cie Inte Method of polymerizing monosaccharides
US2436967A (en) 1942-04-01 1948-03-02 Corn Prod Refining Co Polymerization of sugars
US2719179A (en) 1951-01-25 1955-09-27 Mora Peter Tibor Branched-chain carbohydrate polymers and their preparation
US3766165A (en) 1966-08-17 1973-10-16 Pfizer Polysaccharides and their preparation
US3876794A (en) 1972-12-20 1975-04-08 Pfizer Dietetic foods
US3973049A (en) 1974-03-14 1976-08-03 General Foods Corporation Method of mixing flavors and fixed composition comprising derivatized synthetic polysaccharides
US4671967A (en) 1984-05-18 1987-06-09 Wm. Wrigley Jr. Company Carbohydrate syrups and methods of preparation
GB8519416D0 (en) 1985-08-01 1985-09-04 Unilever Plc Oligosaccharides
US4965354A (en) 1988-02-26 1990-10-23 Taito Company, Ltd. Process for producing a condensed polysaccharide
US4927811A (en) 1988-11-15 1990-05-22 Coors Biotech, Inc. Method and composition for improved animal husbandry
US5667593A (en) 1989-01-26 1997-09-16 Cultor Ltd. Modified polydextrose and process therefor
US5051500A (en) 1989-08-11 1991-09-24 A. E. Staley Manufacturing Company Method of preparing a randomly-bonded polysaccharide
US5397863A (en) 1991-09-13 1995-03-14 International Business Machines Corporation Fluorinated carbon polymer composites
AU659896B2 (en) 1991-12-27 1995-06-01 Matsutani Chemical Industries Co., Ltd. Feed for livestock which contains galacto-oligosaccharides
JPH06121693A (ja) 1992-08-25 1994-05-06 Akebono Brake Res & Dev Center Ltd 高重合度オリゴ糖の製造法
FR2697023B1 (fr) 1992-10-16 1994-12-30 Roquette Freres Polymère soluble hypocalorique du glucose et procédé de préparation de ce polymère .
JPH0770165A (ja) 1993-06-28 1995-03-14 Hayashibara Biochem Lab Inc 非還元性オリゴ糖とその製造方法並びに用途
DE69424794D1 (de) 1993-09-24 2000-07-06 Procter & Gamble Neue oligosaccharid-enthaltende 14-aminosteroidverbindungen und neuer diastereoselektive aminosteroid verfahren chemie
FR2712891B1 (fr) 1993-11-22 1996-02-02 Roquette Freres Procédé de purification d'un polymère soluble hypocalorique du glucose et produit ainsi obtenu.
NL9400040A (nl) 1994-01-10 1995-08-01 Suiker Unie Werkwijze voor het bereiden van polysaccharidederivaten.
US5843922A (en) 1994-07-29 1998-12-01 Fuisz Technologies Ltd. Preparation of oligosaccharides and products therefrom
DK0699689T3 (da) * 1994-08-19 2000-05-08 Nestle Sa Forgrenet polysaccharid, mikroorganisme, der producerer dette, samt præparater indeholdende disse
JP3413062B2 (ja) 1996-06-19 2003-06-03 キヤノン株式会社 糖鎖高分子化合物を含む高分子化合物及びその分解方法
US6475552B1 (en) 1997-03-19 2002-11-05 Danisco Finland Oy Polymerization of mono and disaccharides using low levels of polycarboxylic acids
US6559302B1 (en) 1997-03-19 2003-05-06 Pankaj Shashikant Shah Polymerization of mono-and disaccharides using low levels of mineral acids
AU6571898A (en) 1997-03-19 1998-10-12 Cultor Food Science, Inc. Polymerization of mono- and disaccharides using low levels of polycarboxylic acids
AUPO888497A0 (en) 1997-09-01 1997-09-25 Australian National University, The Use of sulfated oligosaccharides as inhibitors of cardiovascular disease
EP1076716A1 (en) 1998-05-05 2001-02-21 McNeil Speciality Products Company Division of McNeil-PPC Inc. Functional sugar polymers from inexpensive sugar sources and apparatus for preparing same
FR2786775B1 (fr) 1998-12-04 2001-02-16 Roquette Freres Maltodextrines branchees et leur procede de preparation
DE19860376A1 (de) 1998-12-28 2000-07-06 Aventis Res & Tech Gmbh & Co Alpha-1,4 Glucanketten enthaltende Polysaccharide sowie Verfahren zu ihrer Herstellung
US6977245B2 (en) 1999-04-12 2005-12-20 The United States Of America As Represented By The Department Of Health And Human Services Oligodeoxynucleotide and its use to induce an immune response
JP2001086999A (ja) * 1999-09-22 2001-04-03 Oji Paper Co Ltd キシロオリゴ糖含有組成物およびガン細胞アポトーシス誘導剤
JP2003514913A (ja) 1999-11-24 2003-04-22 マサチューセッツ インスティテュート オブ テクノロジー 多糖、天然生成物及びコンビナトリアル・ライブラリの合成に有用な保護基
DE19961182B4 (de) * 1999-12-18 2006-01-12 Südzucker AG Mannheim/Ochsenfurt Galactomannan-Oligosaccharide und Verfahren zu deren Herstellung sowie deren Verwendung
US7608291B2 (en) 2000-03-10 2009-10-27 Mars, Inc. Treatment of infection in animals
CA2432884C (en) 2000-12-27 2008-01-22 N.V. Nutricia Nutritional composition with health promoting action containing oligosaccharides
EP1243273A1 (en) * 2001-03-22 2002-09-25 Societe Des Produits Nestle S.A. Composition comprising a prebiotic for decreasing infammatory process and abnormal activation of non-specific immune parameters
DE10147100A1 (de) * 2001-09-25 2003-04-17 Numico Res B V Antiinfektive Kohlenhydrate
NZ515869A (en) 2001-11-30 2003-09-26 Med Chem Ingredients Ltd Compositions and methods for animal treatment comprising gluco- and isomalto- oligosaccharides
KR20030069454A (ko) 2002-02-20 2003-08-27 주식회사한국신약 펠리누스 린테우스에서 추출한 다당류와5-플루오로우라실을 포함하는 복합 항암제
JP2005531611A (ja) 2002-06-07 2005-10-20 ズートツッカー アクチェンゲゼルシャフト マンハイム／オクセンフルト ガラクトシル・イソマルト、その製造方法及び使用
EP1531832B1 (en) 2002-06-28 2009-04-15 Glykos Finland Oy Therapeutic compositions for use in prophylaxis or treatment of diarrheas
JP2005533525A (ja) 2002-07-23 2005-11-10 ニオズ テクノロジーズ インコーポレイテッド 細菌グリコシルトランスフェラーゼを用いたオリゴ糖、糖脂質、及び糖タンパク質の合成
MXPA05002116A (es) 2002-08-23 2005-06-03 Du Pont Utilizacion de productos de almidon para produccion biologica por fermentacion.
US20040052915A1 (en) 2002-09-13 2004-03-18 Carlson Ting L. Use of low glycemic index sweeteners in food and beverage compositions
AU2003264488A1 (en) * 2002-09-19 2004-04-08 Orient Cancer Therapy Co., Ltd. Immunotherapeutic for cancer
FI20021772A7 (fi) 2002-10-04 2004-04-05 Biotie Therapies Oyj Uudet hiilihydraattikoostumukset ja menetelmä niiden valmistamiseksi
JP3899462B2 (ja) * 2002-12-02 2007-03-28 独立行政法人農業・食品産業技術総合研究機構 ガン細胞アポトーシス誘導剤
GB0229015D0 (en) 2002-12-12 2003-01-15 Novartis Nutrition Ag New Compound
CA2467695C (en) * 2003-05-20 2010-03-16 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Isomaltooligosaccharides from leuconostoc as neutraceuticals
JP4599295B2 (ja) 2003-05-22 2010-12-15 独立行政法人科学技術振興機構 α−選択的グリコシル化反応方法
EP1644482B2 (en) 2003-06-30 2014-10-01 Clasado Inc. Novel galactooligosaccharide composition and the preparation thereof
JP4597630B2 (ja) 2003-10-29 2010-12-15 株式会社神戸製鋼所 表面処理方法及び装置
CN1562050A (zh) 2004-03-24 2005-01-12 中国海洋大学 褐藻酸寡糖在抗痴呆、抗糖尿病中的应用
EP1634599A1 (en) * 2004-08-20 2006-03-15 N.V. Nutricia Iimmune stimulatory infant nutrition
FR2874825B1 (fr) 2004-09-08 2006-12-08 Genibio Sarl Utilisations d'oligosaccharides prebiotiques benefiques pour la flore vaginale
US20060093592A1 (en) 2004-10-04 2006-05-04 Nutracea Synbiotics
CN1255041C (zh) 2004-10-27 2006-05-10 李向群 一种甲壳胺饲料添加剂的制备方法
DE102004058811A1 (de) 2004-12-07 2006-06-08 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Verfahren zur Herstellung von Zuckeralkoholen
FR2884422B1 (fr) 2005-04-18 2008-04-11 Roquette Freres Composition anti-inflammatoire de l'intestin comprenant des maltodextrines branchees
WO2007010084A2 (en) * 2005-07-15 2007-01-25 Johannes Savolainen Immunostimulatory oligo- and polysaccharides and uses thereof
WO2007015937A1 (en) 2005-07-27 2007-02-08 Cantabria Group Lcc Phosphorytated glucomannan polysaccharides containing 1-6 and 1-2 linkages increase weight gain in swine
US20070048432A1 (en) 2005-08-25 2007-03-01 Archer-Daniels-Midland Company Use of dextrin in animal feeds
JP5030960B2 (ja) 2005-10-24 2012-09-19 ネステク ソシエテ アノニム 食物繊維製剤及び投与方法
DE602006008985D1 (de) 2005-12-16 2009-10-15 Nutricia Nv Zusammensetzung enthaltend oligosaccharide als lösliche ballaststoffe zur verwendung gegen muskelschwund
US7608436B2 (en) 2006-01-25 2009-10-27 Tate & Lyle Ingredients Americas, Inc. Process for producing saccharide oligomers
US8993039B2 (en) 2006-01-25 2015-03-31 Tate & Lyle Ingredients Americas Llc Fiber-containing carbohydrate composition
US8057840B2 (en) 2006-01-25 2011-11-15 Tate & Lyle Ingredients Americas Llc Food products comprising a slowly digestible or digestion resistant carbohydrate composition
FR2897869B1 (fr) 2006-02-28 2011-05-06 Roquette Freres Polymeres solubles de glucose hautement branches pour la nutrition enterale, parenterale et pour la dialyse peritoneale
US7915235B2 (en) 2006-03-20 2011-03-29 Brian Dieckgraefe High affinity ligands bind to clostridium difficile toxin A
AU2007352136A1 (en) 2006-04-05 2008-12-04 Oklahoma Medical Research Foundation O-glycans in the treatment of inflammatory bowel disease and cancers
CN101460183A (zh) 2006-04-10 2009-06-17 亚历山大·弗拉基米罗维奇·迪科夫斯基 肠道吸附剂和益生素组合物、用药形式及消化道紊乱的预防和治疗方法
EP1887017A1 (en) 2006-08-09 2008-02-13 Friesland Brands B.V. Prebiotic carbohydrate
US20080069861A1 (en) 2006-09-19 2008-03-20 National Starch And Chemical Investment Holding Corporation Probiotic/Non-Probiotic Combinations
FI20065593L (fi) 2006-09-26 2008-03-27 Valio Oy Menetelmä galakto-oligosakkarideja sisältävien tuotteiden valmistamiseksi ja niiden käyttö
KR20080047956A (ko) 2006-11-27 2008-05-30 주식회사 엠디바이오알파 발기부전의 치료 및 예방을 위한 약제 조성물
US20130216693A1 (en) 2007-01-24 2013-08-22 Tate & Lyle Ingredients Americas Llc Fiber-containing carbohydrate composition
ES2304223B2 (es) 2007-03-08 2009-05-01 Universidad De Sevilla Nuevos caramelos con elevado contenido en oligosacaridos prebioticos, procedimiento de preparacion y utilizacion.
US8197872B2 (en) 2007-05-17 2012-06-12 The Regents Of The University Of California Human milk oligosaccharides to promote growth of beneficial gut bacteria
WO2008156354A1 (en) * 2007-06-21 2008-12-24 N.V. Nutricia Modulation of intestinal flora of hiv patients
CN101801919A (zh) 2007-06-29 2010-08-11 都柏林伊丽莎白女皇神学院 治疗胃肠疾病的靶向重氮前药
ES2337510T3 (es) 2007-07-13 2010-04-26 Stryker Trauma Gmbh Pieza manual ultrasonica.
AU2008318343B2 (en) 2007-11-02 2013-07-18 Dilafor Ab Non-anticoagulant polysaccharide compositions
EP2589302B1 (en) 2007-12-21 2016-11-23 N.V. Nutricia Use of sphingomyelin and non-digestible carbohydrates for improving intestinal microbiota
ITBA20080008A1 (it) 2008-02-22 2009-08-23 Michele Barone Composizioni comprendenti fitoestrogeni selettivi per il recettore estrogenico beta e fibre dietetiche
US9301540B2 (en) 2008-06-09 2016-04-05 Georgia-Pacific Panel Products Llc Prebiotic composition and methods of making and using the same
ES2416086T3 (es) 2008-12-10 2013-07-30 Katholieke Universiteit Leuven Alimento que contiene arabinoxilano y oligosacáridos
CA2760999A1 (en) 2009-03-13 2010-09-16 Mariana Barboza Prebiotic oligosaccharides
GB0906983D0 (en) 2009-04-23 2009-06-03 Clasado Inc Novel use
KR101783383B1 (ko) 2009-05-07 2017-09-29 테이트 ＆ 라일 인그레디언츠 프랑스 에스에이에스 알파-(1,2)-분지형 알파-(1,6) 올리고덱스트란을 제조하기 위한 조성물 및 방법
EP2248907A1 (en) 2009-05-08 2010-11-10 Rijksuniversiteit Groningen Gluco-oligosaccharides comprising (alpha 1-->4) and (alpha 1-->6) glycosidic bonds, use thereof, and methods for providing them
BRPI0925002A2 (pt) 2009-05-27 2016-06-21 Clasado Inc uso de uma composição para a prevenção de diarréia
WO2010143940A1 (en) 2009-06-12 2010-12-16 N.V. Nutricia Synergistic mixture of beta-galacto-oligosaccharides with beta-1,3 and beta-1,4/1,6 linkages
CN102497868A (zh) * 2009-07-15 2012-06-13 N.V.努特里奇亚 用于刺激免疫系统的不可消化低聚糖的混合物
US8691792B2 (en) 2009-08-05 2014-04-08 Nestec Sa Methods and compositions for improving gastrointetinal health
DE202010009591U1 (de) 2010-02-19 2011-03-31 Krüger Gmbh & Co. Kg Neue Süßstoffzusammensetzungen
DE102010012282A1 (de) 2010-03-22 2011-09-22 Fresenius Medical Care Deutschland Gmbh Pharmazeutische Zusammensetzung enthaltend Cyclodextrin-Copolymer
BE1019290A5 (nl) 2010-04-14 2012-05-08 Nutrition Sciences Nv Sa Voedingsupplement omvattende oligosachariden en middellange keten vetzuren.
EP3401410B1 (en) 2010-06-26 2020-12-30 Virdia, Inc. Methods for production of sugar mixtures
EP2401925B1 (fr) 2010-06-29 2014-05-07 Rosebud AG Produit prebiotique et procede de fabrication
US20120034366A1 (en) 2010-08-05 2012-02-09 Tate & Lyle Ingredients Americas, Inc. Carbohydrate compositions
EP2465507A1 (en) 2010-11-23 2012-06-20 Nestec S.A. Oligosaccharide composition for treating skin diseases
JP2012158526A (ja) 2011-01-31 2012-08-23 Niigata Institute Of Science & Technology Niigata Univ Of Pharmacy & Applied Life Sciences マンノオリゴ糖の製造法
US20140187474A1 (en) 2011-02-16 2014-07-03 The Board Of Trustees Of The Leland Stanford Junior University Therapeutic use of mucin glycans
AU2012223494B2 (en) 2011-02-28 2017-04-06 Dsm Nutritional Products, Llc Polymeric acid catalysts and uses thereof
AU2012257395A1 (en) 2011-05-13 2013-12-12 Glycom A/S Method for generating human milk oligosaccharides (HMOs) or precursors thereof
BR112014001472A2 (pt) * 2011-07-22 2017-02-21 Abbott Lab galactooligossacarídeos para prevenir lesões e / ou promover a cicatrização do trato gastrointestinal
US9463169B2 (en) 2011-08-17 2016-10-11 Microbiome Therapeutics, Llc Human gastrointestinal microbiome modulating food supplement for improving blood glucose regulation
US20150087616A1 (en) 2011-11-30 2015-03-26 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
FR2987360B1 (fr) 2012-02-28 2014-03-28 Roquette Freres Maltodextrines hyperbranchees hypo-glycemiantes
EP2666788A1 (en) 2012-05-21 2013-11-27 Nederlandse Organisatie voor toegepast -natuurwetenschappelijk onderzoek TNO Glucan fibre
KR20150047583A (ko) 2012-08-24 2015-05-04 미도리 리뉴어블즈 인코퍼레이티드 중합체 촉매와 고체-지지된 촉매, 및 이러한 촉매를 사용하여 셀룰로오스 물질을 분해하는 방법
US20150202607A1 (en) 2012-08-24 2015-07-23 Midori Renewables, Inc. Polymeric and solid-supported catalysts, and methods of digesting cellulosic materials using such catalysts
US9238845B2 (en) 2012-08-24 2016-01-19 Midori Usa, Inc. Methods of producing sugars from biomass feedstocks
WO2014032004A1 (en) 2012-08-24 2014-02-27 Midori Renewables, Inc. Polymeric and solid-supported catalysts, and methods of digesting lignin-containing materials using such catalysts
BR112015005772A2 (pt) * 2012-09-17 2017-08-08 Galectin Therapeutics Inc método para a intensificação de imunoterapias específicas no tratamento de câncer
US9045804B2 (en) 2013-01-08 2015-06-02 Wisconsin Alumni Research Foundation Method to produce water-soluble sugars from biomass using solvents containing lactones
DK2769726T3 (en) 2013-02-21 2019-02-25 Jennewein Biotechnologie Gmbh Synthetic or recombinant fucosylated oligosaccharides for use in the treatment of infections
KR20150132400A (ko) 2013-03-14 2015-11-25 미도리 유에스에이 인코퍼레이티드 중합체 이온성 염 촉매 및 그 제조방법
WO2014145276A1 (en) 2013-03-15 2014-09-18 Cargill, Incorporated Carbohydrate compositions
WO2014142938A1 (en) 2013-03-15 2014-09-18 Aihol Corporation Pharmaceutical formulation containing glycosaminoglycan
EP2994161B1 (en) * 2013-05-10 2020-10-28 California Institute of Technology Probiotic prevention and treatment of colon cancer
EP3125905A4 (en) 2014-04-04 2017-11-08 Ritter Pharmaceuticals, Inc. Methods and compositions for microbiome alteration
CN104171365A (zh) 2014-07-02 2014-12-03 中泰和（北京）科技发展有限公司 一种提高仔猪断奶重的母猪饲料添加剂及其应用方案
US10752705B2 (en) 2014-07-09 2020-08-25 Cadena Bio, Inc. Oligosaccharide compositions and methods for producing thereof
HK1246800A1 (zh) 2015-01-26 2018-09-14 Cadena Bio, Inc. 用於营养组合物的寡糖组合物和其制造方法
ES2857557T3 (es) 2015-01-26 2021-09-29 Kaleido Biosciences Inc Compuestos terapéuticos de glicano y métodos relacionados de los mismos
EP4205553A1 (en) 2015-01-26 2023-07-05 DSM Nutritional Products, LLC Oligosaccharide compositions for use animal feed and methods of producing thereof
HK1246604A1 (zh) 2015-01-26 2018-09-14 Cadena Bio, Inc. 用作食品成分的寡糖组合物和其制造方法
US9492473B2 (en) 2015-01-26 2016-11-15 Kaleido Biosciences, Inc. Glycan therapeutics and related methods thereof
FR3032709B1 (fr) 2015-02-16 2017-02-24 Roquette Freres Malto-oligo-saccharides riches en fibres et presentant une faible biosdisponibilite en glucose, leur procede de fabrication et leurs utilisations en nutrition humaine et animale
SG11201708635QA (en) 2015-04-23 2017-11-29 Kaleido Biosciences Inc Microbiome regulators and related uses thereof
CA2983236A1 (en) 2015-04-23 2016-10-27 Kaleido Biosciences, Inc. Glycan therapeutics and methods of treatment
WO2017083520A1 (en) 2015-11-13 2017-05-18 Cadena Bio, Inc. Animal therapeutic and feed compositions and methods of use
ES2967947T3 (es) 2016-12-06 2024-05-06 Dsm Nutritional Products Llc Polímeros de glicano y métodos relacionados de los mismos
US11484547B2 (en) 2018-01-08 2022-11-01 Performance Labs PTE. LTD. Compositions and methods for cholesterol, glucose and microbiome control

Also Published As

Publication number Publication date
AU2016253010B2 (en) 2021-06-10
US20240108642A1 (en) 2024-04-04
AU2016253010A1 (en) 2017-10-19
LT3285777T (lt) 2021-11-25
JP2021001208A (ja) 2021-01-07
EP3964234A1 (en) 2022-03-09
ES2895725T3 (es) 2022-02-22
US11883422B2 (en) 2024-01-30
JP2018517677A (ja) 2018-07-05
WO2016172657A2 (en) 2016-10-27
EP3285777A2 (en) 2018-02-28
EP3285777B1 (en) 2021-06-09
DK3285777T3 (da) 2021-08-30
CN107771083A (zh) 2018-03-06
US20210401861A1 (en) 2021-12-30
CA2983236A1 (en) 2016-10-27
AU2021203398A1 (en) 2021-06-24
WO2016172657A3 (en) 2016-12-01
CN116270718A (zh) 2023-06-23
US20190091249A1 (en) 2019-03-28
US10894057B2 (en) 2021-01-19
US12377113B2 (en) 2025-08-05
US20180147221A1 (en) 2018-05-31
HK1251455A1 (zh) 2019-02-01

Similar Documents

Publication Publication Date Title
IL286316A (en) New micro-dystrophins and related method of use
SI3285777T1 (sl) Glikanski terapevtiki in postopki zdravljenja
IL277342B (en) Glycan therapy and related methods
IL290571A (en) Molecules that bind pd-1 and methods of using them
IL256179A (en) lag-3 binding molecules and methods of using them
IL253161B (en) Glycan conjugates and methods for using them
IL282482A (en) Variants of protoxin-II and methods of use
IL282508A (en) Variants of protoxin-II and methods of use
IL254825A0 (en) Methods of treatment with Tesalisib
GB201511799D0 (en) Composition and methods of treatment
GB201621737D0 (en) Compositions and methods of treatment
GB201605127D0 (en) Composition and methods of treatment
GB201417248D0 (en) Compostion and methods of treatment
GB201503371D0 (en) Methods of screening and treatment
GB201512139D0 (en) Methods of treatment
GB201522615D0 (en) Methods of screening and treatment
GB201505437D0 (en) Methods of screening and treatment
GB201503392D0 (en) Methods of screening and treatment
GB201421511D0 (en) Methods of screening and treatment